The company said Monday that fosigotifator failed to outperform placebo in slowing the neurodegenerative disease, but is testing it further and for other conditions.

Alphabet is the mother company of Google. Google’s (GOOGL) anti-aging company Calico released disappointing trial results of its first ever drug. Calico’s fosigotifator was tested for amyotrophic lateral sclerosis (ALS),

Calico, Google's anti-aging subsidiary, has announced disappointing results from its first-ever drug trial. The experimental drug, fosigotifator, was tested as a potential treatment for amyotrophic lateral sclerosis (ALS).